جستجوی استاد راهنمای دانشگاهی

Prof.ssa Elda Favari is a Full-Time Associate Professor of Pharmacology at the Department of Food and Drug, University of Parma, Italy . Her research focuses on atherosclerosis physiology , cholesterol metabolism , and cellular cholesterol efflux processes . She has collaborated with international institutions in the USA , Australia , and Switzerland . PhD in Pharmacology and Toxicology (University of Parma, 2005) Academic Editor for the journal Medicine Member of Italian Society of Pharmacology , European Lipoprotein Club , and International Atherosclerosis Society Her scientific contributions include over 50 peer-reviewed publications , an H-index of 23 , and 16 Q1-journal publications from the last 15 years. Key research areas cover reverse cholesterol transport , PCSK9 mechanisms , and HDL functionality in diseases like familial hypercholesterolemia , cancer , and autoimmune disorders . Recent Google Scholar publications (2023-2025) examine: HDL modulation through nutraceuticals and 3D-printed devices Immune checkpoint inhibitors in relation to lipid profiles PCSK9-lomitapide interactions in genetic lipid disorders Anti-ApoA-1 IgGs as atherogenic factors 2000: AstraZeneca Grant at SISA Congress 2011: National Research Grant for Lupus Study She has held institutional roles including Student Orientation Delegate and serves on scientific committees for international congresses. Teaching spans Toxicology , Anticancer Chemotherapy , and Pharmacovigilance across Pharmacy , Food Safety , and Drug Sciences programs.

• Pharmacology
• Toxicology
• Atherosclerosis
• +۳ مورد دیگر

Mara Bonelli is an Associate Professor in the Department of Medicine and Surgery at the University of Parma, Italy, teaching General Pathology across Nursing, Medicine and Surgery, and Speech and Language Therapy programs since 2013/2014 with appointments extending to 2025/2026. Education: Graduated with honors in Biological Sciences (1995), University of Parma PhD in Biology and Molecular Pathology (1999), University of Parma Research Focus: Her work centers on translational oncology , developing molecular-targeted and immunotherapeutic strategies for malignant pleural mesothelioma, breast, renal, and lung carcinomas using in vitro cell models and in vivo animal studies to overcome treatment resistance through technological innovation. Publication Trends: 2024 research demonstrates concentrated efforts in NSCLC resistance mechanisms via metabolic targeting (glucose starvation, glucosylceramide synthase) and immunomodulation of antiangiogenic drugs in renal carcinoma to enhance anti-PD-1 efficacy, reflecting interdisciplinary approaches in oncological therapeutics. Collaborations: Actively partners with Italian and international research groups in translational oncology initiatives.

• Translational Medicine
• Oncology
• Cancer Research
• +۳ مورد دیگر

Pier Giorgio Petronini is a Full Professor of General Pathology at the University of Parma, leading the Experimental Oncology Laboratory within the Department of Medicine and Surgery. He has held research positions at the Pasteur Institute in Paris and serves on the Novartis Oncology Advisory Board, as Academic Editor for PLOS ONE, and reviewer for multiple journals. Scientific Director of Chiara Tassoni Association for Leukemia Research and Augusto per la Vita Association Member of Italian Society of Cancerology, European Association for Cancer Research, and American Society for Investigative Pathology His research focuses on translational molecular oncology in lung, breast cancer, and malignant pleural mesothelioma, emphasizing preclinical therapeutic strategies. Key projects include targeting CDK4/6, EGFR, and PD-L1 pathways, with recent work on metabolic adaptations in drug-resistant cancers. Selected publications highlight advancements in: CDK4/6-PI3K/AKT/mTOR combination therapy for TNBC FGFR2-MEK synergy in cancers of unknown primary PD-L1-STAT signaling in NSCLC angiogenesis He coordinates grants from AIRC, Novartis, AstraZeneca, and Chiesi Farmaceutici, and holds patents for irreversible EGFR and MDR1 inhibitors.

• Translational Molecular Oncology
• Lung Cancer
• Breast Cancer
• +۱ مورد دیگر

Dr. Kathleen Curtius is an Assistant Professor in the Department of Medicine at the University of California San Diego (UCSD), affiliated with the Division of Biomedical Informatics and the UCSD Moores Cancer Center. She leads the Quantitative Cancer Control laboratory, focusing on early cancer detection and prevention through mathematical modeling and multi-scale data analysis. Previously, she held a Medical Research Council Rutherford Fellowship at Barts Cancer Institute (London) and completed postdoctoral training in Prof. Trevor Graham's lab. Her research integrates applied mathematics, computational biology, and clinical oncology to address cancer evolution and screening strategies. Education: PhD in Applied Mathematics, University of Washington (2015) MS in Applied Mathematics, University of Washington (2011) BS in Mathematics, UCLA (2010) Research Interests: Mathematical oncology Cancer evolution modeling Epigenetic drift analysis Screening optimization Multiscale tumor dynamics Her work bridges disciplines to develop predictive tools for early cancer detection and personalized surveillance strategies. Publications: Recent work includes studies on metagenomic data bias (Nature Communications 2025), AI-driven cancer biomarker discovery (JCI Insight 2022), and computational models of Barrett's esophagus progression (Gut 2020). Her research emphasizes translational applications in clinical oncology and public health. Awards: Recognized with the 2024 Leah Edelstein-Keshet Prize, 2022 AGA Research Scholar Award, and 2018 MRC Rutherford Fellowship. Her work has been cited over 1,000 times across key oncology journals. Funding: Principal Investigator on NIH grants (R01CA270235, I01BX005958) supporting projects on Barrett's esophagus modeling and colitis-associated colorectal cancer surveillance optimization. Collaborates with clinicians, geneticists, and computational biologists to advance cancer control efforts. Labs/Teams: Leads the Quantitative Cancer Control Lab at UCSD, part of the Bioinformatics and Systems Biology division. Active in interdisciplinary initiatives like the Moores Cancer Center's Cancer Control Program.

• Mathematical oncology
• Cancer evolution
• Multiscale modeling
• +۴ مورد دیگر

Francesco Neri is a Professor at the Department of Life Sciences and Systems Biology (DBIOS) at the University of Turin, Italy. His research focuses on the epigenetic mechanisms underlying aging and cancer development, particularly in intestinal stem cells. He leads the Epigenetics of Aging & Cancer Lab located at the Molecular Biotechnology Center (MBC) "Guido Tarone" in Turin and maintains collaborations with the Leibniz Institute on Aging – Fritz Lipmann Institute (FLI) in Jena, Germany. Professor Neri's research interests span several interconnected areas related to aging and disease: Epigenetic drift and DNA methylation changes during aging Intestinal stem cell biology and regeneration in aging Inflammaging (age-related chronic inflammation) Gut microbiome dysbiosis in elderly individuals Development of dietary interventions for healthy aging Colon cancer development and epigenetic mechanisms His research group employs cutting-edge technologies including single-cell RNA sequencing, organoid culture systems, and various genome-wide approaches (RNA-seq, ChIP-seq, ATAC-seq, Bisulfite-seq) to investigate the molecular mechanisms connecting aging with intestinal dysfunction and cancer. Recent work has revealed important connections between interferon gamma signaling, intestinal stem cell function, and tissue regeneration in aging. Professor Neri's publication record demonstrates a strong focus on aging, epigenetics, and intestinal biology, with numerous high-impact publications in journals such as Nature Communications, Cell Reports, and Nature Reviews. His work shows a clear trajectory from fundamental epigenetic mechanisms to translational applications in aging and cancer. His research has important implications for developing interventions to improve intestinal health in elderly individuals and potentially prevent age-related diseases including cancer.

• Epigenetics
• Aging Research
• Cancer Biology
• +۵ مورد دیگر

Paola Falletta is a Fixed-term Researcher at San Raffaele University, specializing in Human Anatomy (BIO/16) within the College of Medicine. Her research focuses on cancer biology, particularly melanoma progression mechanisms, transcription factor regulation, and metabolic reprogramming. Academic Rank: Researcher Department: Human Anatomy Key Research Areas: Phenotypic Plasticity, Autophagy, DNA Damage Repair Her work investigates how melanoma cells adapt metabolically and transcriptionally to environmental stresses, with significant publications in Nature Communications , Genes & Development , and Pigment Cell & Melanoma Research . Recent studies highlight MITF's role in fatty acid regulation, BRN2-mediated DNA repair, and chromatin organization's impact on nuclear factor dynamics. Publications (2014-2023) demonstrate sustained expertise in melanoma biology, stress response pathways, and organelle-specific protein regulation. She teaches multiple anatomy courses for medical and health informatics programs. Contact: falletta.paola@hsr.it | falletta.paola@unisr.it

• Cancer Biology
• Molecular Biology
• Transcription Factors
• +۴ مورد دیگر

Antonio SICA is a Full Professor in the Department of Pharmaceutical Sciences at the University of Eastern Piedmont 'Amedeo Avogadro'. With an extensive research career spanning over three decades, he has published 189 research outputs including articles, reviews, and conference contributions. His ORCID profile (0000-0002-8342-7442) documents his significant contributions to immunology and cancer research. Professor SICA's research primarily focuses on myeloid cells in cancer , particularly tumor-associated macrophages and myeloid-derived suppressor cells . His work explores how these cells contribute to tumor progression, immunosuppression, and response to therapy. Key research areas include immunometabolism, epigenetic regulation of myeloid cells, and the intersection of inflammation with cancer development. Analysis of his recent publications (2021-2024) reveals a strong emphasis on myeloid cell heterogeneity in cancer, immunometabolic pathways , and the role of myeloid cells in age-related diseases . His 2023-2024 work has particularly examined connections between cancer immunology and infectious diseases like COVID-19, demonstrating how immunometabolic interference affects disease outcomes. Advancing the knowledge of human neutrophils displaying polymorphonucler myeloid-derived suppressor cell (PMN-MDSC) functions (2023-2025) BioTher19: Biological bases of immune response in fragile COVID-19 patients Deciphering the molecular and functional heterogeneity of myeloid cells in cancer (2019-2023) Deciphering the epigenetic basis of Myeloid-derived immunosuppression in cancer and therapy (2018-2023) Professor SICA has supervised 5 students throughout his career and maintains active research collaborations across multiple institutions. His work contributes significantly to UN Sustainable Development Goals related to good health and well-being, particularly through advancing cancer immunology and immunotherapy approaches.

• Immunology
• Macrophage Biology
• Tumor-associated Macrophages
• +۴ مورد دیگر

Francesca Rappa is a Full Professor in the Department of Human Anatomy and Histology within the School of Medicine and Surgery at the University of Palermo. Her academic position (BIOS-12/A classification) centers on biomedicine, neuroscience, and advanced diagnostics with a focus on molecular mechanisms of disease. Her research spans multiple interconnected domains centered on stress response systems. Key interests include: Molecular chaperone networks (particularly Hsp60, Hsp90, Hsp27) in carcinogenesis Thyroid and colorectal cancer pathophysiology Glioblastoma multiforme molecular characterization Probiotic interventions for gut-liver-muscle axis disorders Nanovesicle-based therapeutics from citrus and tomatoes Diagnostic applications of heat shock proteins in inflammatory diseases Publication analysis reveals consistent focus on chaperone systems across cancer types (thyroid, salivary, colorectal, brain), with recent expansion into nutraceutical mechanisms involving citrus nanovesicles and golden tomatoes. Her 2023-2025 output shows increasing emphasis on multi-organ communication pathways (gut-brain, gut-liver-muscle) and industrial-scale therapeutic applications. Methodologically, she integrates immunohistochemistry, proteomics, and animal disease models. Teaching responsibilities include core anatomy courses for Medicine and Radiology programs: Anatomy I (10 CFU) and II (6 CFU) for Medicine Human Anatomy with Histology elements (6 CFU) for Radiology Integrated Anatomy/Biochemistry/Physiology modules (12 CFU) She actively supervises graduate research, with four theses directed between 2020-2024 covering celiac disease histopathology, stress protein interactions in colorectal cancer, glioblastoma biomarkers, and thyroid stress responses. Her laboratory work focuses on immunomorphological analysis of chaperone systems in tumor tissues and development of probiotic/nanovesicle interventions for metabolic and inflammatory conditions.

• Molecular Chaperones in Cancer
• Heat Shock Proteins (Hsp60, Hsp90, Hsp27)
• Thyroid Pathology
• +۵ مورد دیگر

Nicola Clementi serves as an Associate Professor of Medical Microbiology and Virology at Vita-Salute San Raffaele University in Milan, Italy, with active clinical and research affiliation at San Raffaele Scientific Institute (IRCCS). His academic credentials include Board Certification in Medical Microbiology and Virology (2010) from Vita-Salute San Raffaele University and a Master's degree in Biological Sciences (2006) from Università Politecnica delle Marche, Ancona. His educational background features: Master of Biological Sciences, Università Politecnica delle Marche, Ancona, Italy (2006) Board Certification in Medical Microbiology and Virology, Vita-Salute San Raffaele University, Milan, Italy (2010) Clementi's research centers on clinical virology and medical microbiology with emphasis on bacterial and viral pathogen dynamics. His work spans sexually transmitted infections (LGV, gonorrhea), emerging viral outbreaks (mpox, SARS-CoV-2), neonatal viral hepatitis , and microbiome-immune interactions in immunotherapy. He employs epidemiological surveillance, mutational profiling, and clinical cohort analysis to address antimicrobial resistance trends and therapeutic efficacy challenges within Italian healthcare settings. His 2024 publications reveal a focus on urgent public health threats through high-impact clinical studies. Key trends include optimizing antibiotic regimens for STIs, investigating immunological mechanisms in viral hepatitis, analyzing SARS-CoV-2 mutational responses to ribavirin therapy, and exploring microbiome modulation to reduce immunotherapy toxicity. The work heavily leverages Italian patient cohorts (Lombardy region) and demonstrates interdisciplinary approaches bridging virology, bacteriology, and immunology. No scientific awards are documented in the provided source material. While formal student lists and grant details are absent from the scraped data, his editorial roles and publication volume suggest active academic mentoring. Clementi serves as Review Editor for Virology at Frontiers in Microbiology and Guest Associate Editor for Experimental Pharmacology at Frontiers in Pharmacology, indicating leadership in scholarly peer review despite no explicit grant mentions. He operates within San Raffaele Scientific Institute (IRCCS) research ecosystem, evidenced by co-authorship with clinicians and microbiologists from this tertiary hospital. His network includes collaborators like Gabriel Siracusano (IRCCS) and Mauro Pistello (University of Pisa), with 46 active professional connections reflecting engagement in Italy's infectious disease community.

• Virology
• Medical Microbiology
• Infectious Diseases
• +۳ مورد دیگر

Francesco Carfi' Pavia is a Researcher (ICHI-01/B) at the Polytechnic School of the University of Palermo . His work focuses on biomedical engineering, polymer science, and tissue engineering, particularly scaffold fabrication for 3D cell culture systems. Research Interests : His research spans scaffold design for bone and tissue regeneration, computational modeling of bioreactors, and microbial bioremediation studies. He explores advanced fabrication techniques like thermally induced phase separation (TIPS) and galvanic deposition for biomedical applications. Publications Trends : His recent articles emphasize 3D scaffold development for cancer models, orthopedic implants, and microbial adaptation to toxicants, with applications in drug delivery, tissue regeneration, and biodegradable materials. Contact : Email: francesco.carfipavia@unipa.it Office hours: Wednesdays and Thursdays, 3:00 PM–6:00 PM, Building 6, Third Floor.

• Tissue Engineering
• Biomedical Engineering
• Polymer Science
• +۳ مورد دیگر

Lorenzo Farina is a Full Professor at Sapienza University of Rome's Faculty of Information Engineering, Computer Science and Statistics, specializing in Electronic and Computer Bioengineering (ING-INF/06). With over 25 years of academic leadership, he co-founded Italy's first Bioinformatics degree program and established key oncology precision medicine initiatives, maintaining active collaborations with Harvard Medical School's network medicine division. His educational background includes a cum laude Electronic Engineering degree and PhD in Systems Engineering, both from Sapienza University. These foundational studies evolved into pioneering work in positive linear systems theory, evidenced by his highly-cited Wiley textbook Positive Linear Systems: Theory and Applications (2000). Farina's research centers on network medicine – applying complex network science to molecular medicine since his 2004 breakthrough. His work spans cancer mechanisms (breast, glioblastoma, lung), drug repositioning (including COVID-19 applications), and liquid biopsy biomarker development. Current projects focus on miRNA-based network biomarkers for cancer diagnostics and immunotherapy response prediction, integrating multi-omics data through advanced computational frameworks. Analysis of his 15 most recent publications (2024-2025) reveals dominant themes: sexual dimorphism in cancer networks (MIRROR platform), immunotherapy response signatures, and critical examinations of AI's role in precision medicine. His work consistently bridges computational innovation with clinical applications, particularly in oncology diagnostics and therapeutic optimization. His scientific recognition includes: 2001 Guillemin-Cauer Award for best IEEE Transactions on Circuits and Systems article 2014 SysBio Award for annual best publication Farina actively mentors through interdisciplinary programs he established, including the Network Oncology doctoral program. His laboratory collaborations span Sapienza's Oncogenomics and Immunology Laboratories, Harvard's Channing Division of Network Medicine, and clinical departments in oncology and radiology, driving translational research from computational models to patient applications. He leads multiple research teams focused on network-based diagnostics, including the MIRROR platform for cancer disparity analysis and liquid biopsy development teams investigating circulating miRNA networks for early cancer detection across multiple malignancies.

• Network Medicine
• Bioinformatics
• Systems Biology
• +۶ مورد دیگر

Paola Paci is an Associate Professor at the Department of Computer, Control, and Management Engineering "Antonio Ruberti" of Sapienza University of Rome and an Affiliate Professor at the Department of Laboratory Medicine, Cardio-Metabolic Unit of Karolinska Institutet, Sweden. She has held visiting positions at Harvard Medical School and research roles at CNR's Institute for Systems Analysis and Computer Science. Her work bridges computational biology and network medicine. 2010: Second Level Master in Bioinformatics (Sapienza University of Rome) 2003: PhD in Physics (University of Pavia) 1999: MSc in Physics (Sapienza University of Rome) Paci develops algorithms for biomarker discovery and drug repurposing in network medicine. Her tools include SWIM for glioblastoma biomarkers, SPINNAKER for ceRNA interactions, SAveRUNNER for drug repurposing, and MIENTURNET for miRNA-target analysis. Recent work focuses on single-cell multi-omics, adverse drug effects, and pathogen spillover mechanisms. Her research spans 2025-2024 publications covering Alzheimer’s disease drug prioritization, COPD pathway analysis, obesity therapeutics avoiding hepatic steatosis, and neuroblastoma immunotherapy resistance. These works integrate network medicine with pharmacology, genomics, and systems biology. 2018: BITS Best Poster Award 2017: IEEE TCCLS Best Poster (700 USD) 2016: IEEE TCCLS Best Poster (500 USD) 2014: SYSBIO Award (10,000 EUR) 2010: Master Award (1,500 EUR) She teaches bioinformatics at Sapienza University and Campus Biomedico University, organized key IEEE workshops, directs training courses, and serves on editorial boards (Scientific Reports, Biotechnology Reports). Her affiliations include the Network Medicine Institute and GNB bioengineering society.

• Computational Biology
• Bioinformatics
• Network Medicine
• +۳ مورد دیگر

Annalisa Tirella serves as Associate Professor in the Department of Industrial Engineering at the University of Trento, specializing in biomaterials and tissue engineering. Her research focuses on developing advanced 3D models for cancer microenvironments and regenerative medicine applications, with particular expertise in hydrogel engineering and bioprinting technologies. Her primary research interests include Tissue Engineering , Biomaterials Design , and Cancer Microenvironment Modeling , with emphasis on creating physiologically relevant in vitro systems. She investigates how mechanical properties of biomaterials influence cellular behavior in breast and prostate cancer models, develops sustainable biomaterials from circular economy sources, and engineers drug delivery systems using nano-in-micro technologies. Her TERM (Tissue Engineering and Regenerative Medicine) work bridges fundamental biophysical principles with clinical translation. Dr. Tirella teaches advanced courses including Biotechnology Engineering for the Department of Cellular, Computational and Integrative Biology, where she covers TERM applications, biomaterials characterization, and additive manufacturing techniques. Her educational focus emphasizes problem-solving skills for designing biomedical technologies and understanding cell-biomaterial interactions. Her recent publications (2023-2025) reveal strong trends in cancer microenvironment modeling (particularly breast and prostate cancers), hydrogel engineering with alginate and natural polymers, and advanced drug delivery systems . Key research directions include deciphering invasive cancer phenotypes through data-driven approaches, developing tumor-mimetic scaffolds with tunable mechanical properties, and creating sustainable biomaterials for precision medicine applications. The work consistently integrates biomechanical analysis with biological validation. Dr. Tirella actively develops innovative methodologies including microfluidic fabrication, response surface methodology for hydrogel optimization, and nano-in-micro encapsulation techniques. Her research has significant implications for understanding cancer metastasis mechanisms and developing targeted therapeutic approaches.

• Tissue Engineering
• Biomaterials
• Bioprinting
• +۷ مورد دیگر

Ambrosi Alessandro is an Associate Professor in Medical Statistics at Vita-Salute San Raffaele University. Holding a PhD in Statistics from the University of Padua (1999), he has contributed extensively to biostatistical methodologies in medical research, particularly in gene therapy, hematology, and computational biology. Degree in Statistics, University of Padua (1996) PhD in Statistics, University of Padua (1999) His research focuses on non-parametric statistical methods, machine learning applications in medicine, and statistical genetics. He has developed analytical frameworks for retroviral integration site mapping and biomarker discovery in preeclampsia and cancer prognosis. Recent work examines placental gene expression in pregnancy complications, orthodontic biomechanics, and cardiovascular risk prediction models. His publications span top-tier journals such as EMBO, Blood, and Nature Biotechnology. Fellow, Cochrane (2024-present) Fellow, Società Italiana di Statistica (2024-present) Fellow, SISMEC (2013-present) Ambrosi has served as a contract professor at the University of Padua and participates in doctoral colleges across Italy. His collaborations include international institutions like the University of Aarhus (Denmark) and the University of Oslo (Norway).

• Non-parametric statistical methods
• Machine learning
• Statistical methods in genetics
• +۳ مورد دیگر

Kuka Mirela is an Associate Professor of Pathology at Vita-Salute San Raffaele University and a tenure-track Project Leader in the Division of Immunology, Transplantation and Infectious Diseases (DITID) at the San Raffaele Scientific Institute in Milan. She holds a PhD from the University of Siena/Novartis Vaccines and completed postdoctoral training at the NIH (USA) and San Raffaele Scientific Institute. Her research focuses on immune responses to viral infections, B/T cell interactions, and tumor immunology. Research interests include: (1) Regulation of B cell responses by T cells and innate immune cells during viral infections, (2) Role of inflammatory monocytes in suppressing humoral immunity, (3) B cell-mediated anti-tumor immunity and tumor-associated lymphoid structures. She has pioneered studies on how viral infections modulate T follicular helper cells and discovered novel mechanisms of B cell suppression via inflammatory monocytes. Recent publications (2023-2025) investigate T cell therapy efficacy improvement via LSD1 inhibition, antibody-independent SARS-CoV-2 protection, and novel TDC cell biology models. Awards include AAI Early Career Grant (2022) and PRIN2020 coordination (2021). Teaching roles include courses in pathology and immunology for medicine and biomedical programs. Active in professional organizations: Vice-coordinator of the PhD Program in Molecular Medicine, member of AAI, SIICA, and NIBIT. Serves on editorial boards for Frontiers in Immunology and Faculty Opinions .

• Immunology
• Virology
• Cancer Biology
• +۵ مورد دیگر